Please login to the form below

Not currently logged in

GSK's Philip Thomson named Communiquetor of the Year

Recognised for stewardship of pharma company's global communications team

Philip Thomas Communique Awards 2013 

GSK's senior vice president of global communications Philip Thomson won the prestigious Communiquétor of the Year Award at last night's Communiqué Awards. 

The award celebrates an individual in healthcare communications who has gone over and above their day job and demonstrated 'outstanding personal achievement'. 

Thomson, who has worked in media relations at GSK for nearly a decade, was singled out for the accolade for his services to the industry, particularly through his effort to improve its reputation. 

With the industry facing mounting criticism and scrutiny in the past 12 months over the issue of clinical trial data transparency, Thomson helped steer GSK into a position of leadership when it became the first company to sign up to the AllTrials clinical trial transparency campaign

Also during 2012, he oversaw GSK's wide-acclaimed campaign to highlight its roles as the Official Laboratory Services Provider for the London Olympics

“Whilst Sir Andrew Witty, as CEO, gets many of the headlines,” commented the judges, “it is his wing-man Philip who makes things happen, at the same time as driving the media agenda.” 

By receiving this award, only given individuals who have achieved something truly remarkable, Thomson follows last year's winner ABPI head Stephen Whitehead

The Communiqué programme, which took place at London's Grosvenor House Hotel, Park Lane, is run by PMLiVE publishers PMGroup and is specifically designed to recognise and commend excellence and best practice in local, European and international healthcare communications.

• See the full results of the Communiqué Awards 2013
• See all the photos from the Communiqué Awards 2013

4th July 2013

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...